The interpretation of nucleic acid amplification tests for tuberculosis: Do rapid tests change treatment decisions?

Journal of Infection

Volumn 50, Issue 3, 2005, Pages 187-192

  Conaty, S J ^a   Claxton, A P ^a   Enoch, D A ^b   Hayward, A C ^a   Lipman, M C I ^b   Gillespie, S H ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Nucleic acid amplification techniques; Predictive value of tests; Sensitivity and specificity; Tuberculosis; Tuberculosis diagnosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ASCITES FLUID ANALYSIS; BACTERIUM CULTURE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL PRACTICE; CONTROLLED STUDY; EXTRAPULMONARY TUBERCULOSIS; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MEDICAL RECORD; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID AMPLIFICATION; PREDICTION; RETROSPECTIVE STUDY; REVIEW; SENSITIVITY AND SPECIFICITY; SPUTUM SMEAR; TRACHEOBRONCHIAL TOILET; TREATMENT WITHDRAWAL; UNITED KINGDOM;

EID: 14944362460     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2004.03.010     Document Type: Article

References (14)

1. Sackett D.L. Haynes R.B. The architecture of diagnostic research Br Med J 324 7336 2002 539-541
2. Communicable Disease Surveillance Service. Annual report on tuberculosis cases reported in 2000 in England, Wales and Northern Ireland; 2003
3. Styrt B.A. Shinnick T.M. Ridderhof J.C. Crawford J.T. Tenover F.C. Turnaround times for mycobacterial cultures J Clin Microbiol 35 4 1997 1041-1042
4. Davies A.P. Newport L.E. Billington O.J. Gillespie S.H. Length of time to laboratory diagnosis of Mycobacterium tuberculosis infection: Comparison of in-house methods with reference laboratory results J Infect 39 3 1999 205-208
5. Drobniewski F.A. Watterson S.A. Wilson S.M. Harris G.S. A clinical, microbiological and economic analysis of a national service for the rapid molecular diagnosis of tuberculosis and rifampicin resistance in Mycobacterium tuberculosis J Med Microbiol 49 3 2000 271-278
6. Drobniewski F.A. Watt B. Smith E.G. et al. A national audit of the laboratory diagnosis of tuberculosis and other mycobacterial diseases within the United Kingdom J Clin Pathol 52 5 1999 334-337
7. Roth A. Schaberg T. Mauch H. Molecular diagnosis of tuberculosis: current clinical validity and future perspectives Eur Respir J 10 8 1997 1877-1891
8. Lebrun L. Mathieu D. Saulnier C. Nordmann P. Limits of commercial molecular tests for diagnosis of pulmonary tuberculosis Eur Respir J 10 8 1997 1874-1876
9. Rapid diagnostic tests for tuberculosis: What is the appropriate use? American Thoracic Society Workshop. Am J Respir Crit Care Med 1997 155 (5) 1804-14
10. Nucleic acid amplification tests for tuberculosis. MMWR-Morb Mortal Wkly Rep 1996 45 (43) 950-2
11. Update: Nucleic acid amplification tests for tuberculosis. MMWR-Morb Mortal Wkly Rep 2000 49 (26) 593-4
12. Bradley S.P. Reed S.L. Catanzaro A. Clinical efficacy of the amplified Mycobacterium tuberculosis direct test for the diagnosis of pulmonary tuberculosis Am J Respir Crit Care Med 153 5 1996 1606-1610
13. Catanzaro A. Perry S. Clarridge J.E. et al. The role of clinical suspicion in evaluating a new diagnostic test for active tuberculosis: results of a multicenter prospective trial JAMA 283 5 2000 639-645
14. Dowdy D.W. Maters A. Parrish N. Beyrer C. Dorman S.E. Cost-effectiveness analysis of the gen-probe amplified Mycobacterium tuberculosis direct test as used routinely on smear-positive respiratory specimens J Clin Microbiol 41 3 2003 948-953